Adverum Biotechnologies Overview
Adverum Biotechnologies Target Price
Analysts' 12-month price predictions for ADVM.
Get informed when a big investor buys or sells
+ FollowShare Price
$4.36
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-10-29 | Mizuho Securities | $5.5 |  26.1% upside |  |
| 2025-10-28 | RBC Capital | $4 |  8.3% downside | |
| 2025-10-24 | Truist FinancialJoon Lee | $5 | 14.7% upside | |
| 2024-11-05 | RBC CapitalLuca Issi | $10 | 129.4% upside | |
| 2024-10-14 | OppenheimerFrancois Brisebois | $28 | 542.2% upside | |
| 2024-09-20 | Mizuho SecuritiesGraig Suvannavejh | $20 | 358.7% upside | |
| 2024-08-13 | RBC CapitalLuca Issi | $12 | 175.2% upside | |
| 2022-11-11 | Chardan Capital | $2 | 54.1% downside | |